Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free GTBP Stock Alerts

GT Biopharma (GTBP) Stock Chart & Stock Price History

GT Biopharma logo
$6.88 -0.22 (-3.03%)
As of 11:46 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

GT Biopharma Stock Price Performance

The GT Biopharma (GTBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 65.57%, with a year-to-date return of -64.93%. In the past month, the stock has decreased 9.94%, reflecting recent market activity.

As of the latest close, GT Biopharma traded at $7.10 with a market cap of $12.81 million and volume of 53,700 shares. Five years ago, the stock traded at a split-adjusted price of $5,250.00, representing a 99.87% decrease over that period. At the time, it had a market cap of $147.90 million and a volume of 229 shares.

Receive GTBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-3.84%
1 Month
Performance
-9.94%
3 Month
Performance
-39.62%
Year-To-Date
Performance
-64.93%
1 Year
Performance
-65.57%
5 Year
Performance
-99.87%

GTBP Stock Chart for Thursday, September, 24, 2026

GTBP Chart by TradingView

GT Biopharma Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/23/2026$7.18$7.10
-1.11%		$7.28$6.8353,700 shs$12.81 million
09/22/2026$7.18$7.18$7.20$6.3574,057 shs$12.92 million
09/21/2026$7.16$7.18
+0.28%		$7.82$6.8857,664 shs$12.92 million
09/18/2026$7.49$7.16
-4.41%		$7.52$7.1137,469 shs$12.89 million
09/17/2026$7.81$7.49
-4.10%		$7.80$6.33110,549 shs$13.48 million
09/16/2026$9.00$7.81
-13.22%		$9.04$7.31107,212 shs$14.09 million
09/15/2026$11.63$9.00
-22.61%		$10.48$8.13334,046 shs$16.20 million
09/14/2026$8.61$11.63
+35.08%		$11.98$8.65521,269 shs$20.93 million
09/11/2026$6.18$8.61
+39.32%		$8.82$6.59535,275 shs$15.50 million
09/10/2026$5.98$6.18
+3.34%		$6.74$5.50155,745 shs$11.12 million
09/09/2026$5.24$5.98
+14.13%		$6.24$5.12119,648 shs$269.76 million
09/08/2026$6.03$5.24
-13.04%		$5.95$4.9187,471 shs$236.35 million
09/07/2026$6.03$6.03$6.50$5.5546,352 shs$10.87 million
09/04/2026$6.31$6.03
-4.52%		$6.50$5.5546,352 shs$10.87 million
09/03/2026$7.08$6.31
-10.81%		$7.14$6.3144,343 shs$11.39 million
09/02/2026$7.22$7.08
-2.04%		$7.25$7.009,842 shs$12.77 million
09/01/2026$7.15$7.22
+1.01%		$7.25$7.0010,066 shs$13.03 million
08/31/2026$7.50$7.15
-4.67%		$7.97$7.1412,580 shs$12.90 million
08/28/2026$7.55$7.50
-0.60%		$7.85$7.5014,954 shs$13.53 million
08/27/2026$7.25$7.55
+4.03%		$7.59$7.2715,766 shs$13.61 million
08/26/2026$7.49$7.25
-3.20%		$7.45$7.157,250 shs$13.09 million
08/25/2026$7.65$7.49
-1.99%		$7.87$7.4517,482 shs$13.52 million
08/24/2026$7.22$7.65
+5.96%		$7.95$7.1324,529 shs$13.79 million
Related Companies

This page (NASDAQ:GTBP) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners
The AI Infrastructure Rush Is ON — Watch VDTA
Vertical Data Inc. (OTCQB: VDTA) is targeting the layers beneath the AI boom - GPU hardware and financing, man...
Trading Wire | Sponsoredtc pixel
They're shrinking your dollars every single month
Since 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...
American Alternative | Sponsoredtc pixel
The Pentagon Has 120 Days to Solve This Critical Mineral Problem
China controls roughly 80% of the world's tungsten supply, and new Pentagon sourcing restrictions take effect ...
The Tomorrow Investor | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Wall Street Legend: “I've discovered a fatal flaw built into Elon's AI model”
Wall Street veteran Marc Chaikin says he's found a fatal flaw built into Elon Musk's AI model and every fronti...
Chaikin Analytics | Sponsoredtc pixel
Arizona Gold Explorer Nears First-Ever Resource Estimate
A little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...
Wall Street Logic | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel